Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: Hospital to pay $24.3M over TAVR allegations | Cardiology salary update | 2 new recalls | HRS 2024
Saturday, May 25, 2024
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Hospital to pay $24.3M over TAVR allegations

According to a whistleblower, Cape Cod Hospital performed hundreds of TAVR procedures without following specific government requirements.

READ MORE >
Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule. 
Share on Twitter Share on Facebook Share on Linkedin

Hospital to pay $24.3M over TAVR allegations

Share on Twitter Share on Facebook Share on Linkedin
Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule. 
According to a whistleblower, Cape Cod Hospital performed hundreds of TAVR procedures without following specific government requirements.
READ MORE >

Cardiology salaries are No. 7 among all specialties—thoracic and vascular surgery also make top 10

Physician compensation in the United States is up 6% compared to the previous year, according to a new report. It only increased by 3.9% in cardiology, however, suggesting the specialty is slightly behind the curve.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology salaries are No. 7 among all specialties—thoracic and vascular surgery also make top 10

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Physician compensation in the United States is up 6% compared to the previous year, according to a new report. It only increased by 3.9% in cardiology, however, suggesting the specialty is slightly behind the curve.
READ MORE >

Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days

The balloon-expandable valve is already approved for use in India and Europe. New data presented at EuroPCR 2024 in Paris compared it to contemporary devices seen by many as the gold standard for TAVR care. 

READ MORE >
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
Share on Twitter Share on Facebook Share on Linkedin

Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days

Share on Twitter Share on Facebook Share on Linkedin
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
The balloon-expandable valve is already approved for use in India and Europe. New data presented at EuroPCR 2024 in Paris compared it to contemporary devices seen by many as the gold standard for TAVR care. 
READ MORE >

Business concerns over costs and thin margins means it is no longer enough to just be a cardiologist

Cardiologist Jerry Blackwell, MD, president and CEO of MedAxiom, believes cardiologist can't just focus on clinical decisions, as they also must be aware the financial ramifications. 

READ MORE >
Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom, said iIt is no longer enough to just be a cardiologist making clinical decisions, they also need to be much more aware the business side of healthcare. #Cardiologybusiness #CVBusiness #CMS #Cardiology #ACC #ACC2024 #Medaxiom
Share on Twitter Share on Facebook Share on Linkedin

Business concerns over costs and thin margins means it is no longer enough to just be a cardiologist

Share on Twitter Share on Facebook Share on Linkedin
Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom, said iIt is no longer enough to just be a cardiologist making clinical decisions, they also need to be much more aware the business side of healthcare. #Cardiologybusiness #CVBusiness #CMS #Cardiology #ACC #ACC2024 #Medaxiom
Cardiologist Jerry Blackwell, MD, president and CEO of MedAxiom, believes cardiologist can't just focus on clinical decisions, as they also must be aware the financial ramifications. 
READ MORE >

FDA clears advanced AI model for predicting heart failure risk

The new algorithm from Implicity evaluates implantable device data and monitors patients for changes that suggest they could experience severe heart failure symptoms in the near future. It was designed to alert clinicians up to weeks in advance.

READ MORE >
The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears advanced AI model for predicting heart failure risk

Share on Twitter Share on Facebook Share on Linkedin
The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.
The new algorithm from Implicity evaluates implantable device data and monitors patients for changes that suggest they could experience severe heart failure symptoms in the near future. It was designed to alert clinicians up to weeks in advance.
READ MORE >

Pfizer recalls 2 drugs, including 1 for hypertension, over safety concerns

The recall was put in place due to a leak risk that could make the therapies less effective and potentially lead to an infection. 

READ MORE >
Hospira, an Illinois-based pharmaceutical and medical device company owned by Pfizer, has issued a voluntary recall of two different drugs due to ongoing safety issues. The recall includes specific lots of labetalol hydrochloride injections and buprenorphine hydrochloride injections. Labetalol hydrochloride injections are used to control blood pressure in patients with severe hypertension.
Share on Twitter Share on Facebook Share on Linkedin

Pfizer recalls 2 drugs, including 1 for hypertension, over safety concerns

Share on Twitter Share on Facebook Share on Linkedin
Hospira, an Illinois-based pharmaceutical and medical device company owned by Pfizer, has issued a voluntary recall of two different drugs due to ongoing safety issues. The recall includes specific lots of labetalol hydrochloride injections and buprenorphine hydrochloride injections. Labetalol hydrochloride injections are used to control blood pressure in patients with severe hypertension.
The recall was put in place due to a leak risk that could make the therapies less effective and potentially lead to an infection. 
READ MORE >

AVR for moderate AS: New 10-year data highlight clear benefits of TAVR, surgery

New research out of Cleveland Clinic explored long-term outcomes among patients with moderate aortic stenosis who were treated with TAVR, SAVR or clinical surveillance. TAVR and SAVR were both associated with clear improvements compared to surveillance alone. 

READ MORE >
doctor examines patient data on their tablet
Share on Twitter Share on Facebook Share on Linkedin

AVR for moderate AS: New 10-year data highlight clear benefits of TAVR, surgery

Share on Twitter Share on Facebook Share on Linkedin
doctor examines patient data on their tablet
New research out of Cleveland Clinic explored long-term outcomes among patients with moderate aortic stenosis who were treated with TAVR, SAVR or clinical surveillance. TAVR and SAVR were both associated with clear improvements compared to surveillance alone. 
READ MORE >

Exploring the biggest trends at HRS 2024

Heart Rhythm Society President Jodie Hurwitz, MD, told Cardiovascular Business that pulsed field ablation was one of the hottest topics at Heart Rhythm 2024. It may be early, she said, but the technology is already making an impact. 

READ MORE >
HRS president Jodie Hurwitz, MD, discusses trends in electrophysiology at the 2024 HRS meeting.
Share on Twitter Share on Facebook Share on Linkedin

Exploring the biggest trends at HRS 2024

Share on Twitter Share on Facebook Share on Linkedin
HRS president Jodie Hurwitz, MD, discusses trends in electrophysiology at the 2024 HRS meeting.
Heart Rhythm Society President Jodie Hurwitz, MD, told Cardiovascular Business that pulsed field ablation was one of the hottest topics at Heart Rhythm 2024. It may be early, she said, but the technology is already making an impact. 
READ MORE >

FDA announces new Class I recall of CPET devices due to choking hazard

If left unchecked, the devices could put patients at risk of serious injuries or death as they undergo cardiopulmonary evaluations. 

READ MORE >
The U.S. Food and Drug Administration (FDA) announced that Vyaire Medical has recalled the twin tube samples lines from its Vyntus CPX Metabolic Cart due to ongoing safety concerns. This is a Class I recall, which means the FDA believes using these devices “may cause serious injuries or death.”
Share on Twitter Share on Facebook Share on Linkedin

FDA announces new Class I recall of CPET devices due to choking hazard

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) announced that Vyaire Medical has recalled the twin tube samples lines from its Vyntus CPX Metabolic Cart due to ongoing safety concerns. This is a Class I recall, which means the FDA believes using these devices “may cause serious injuries or death.”
If left unchecked, the devices could put patients at risk of serious injuries or death as they undergo cardiopulmonary evaluations. 
READ MORE >

Cardiologist on hunger strike wants more beds for department—has not eaten in 12 days

The cardiologist has been fasting in his office since May 11. He insists that he and his colleagues need more room to provide care for a growing patient population. 

READ MORE >
doctor_patients.jpg
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist on hunger strike wants more beds for department—has not eaten in 12 days

Share on Twitter Share on Facebook Share on Linkedin
doctor_patients.jpg
The cardiologist has been fasting in his office since May 11. He insists that he and his colleagues need more room to provide care for a growing patient population. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup